Clinical trials
Uveitis, Intermediate trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Terminated | 14 |
| Withdrawn | 6 |
| Unknown status | 5 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 8 |
| Novartis Pharmaceuticals | 6 |
| Clearside Biomedical, Inc. | 5 |
| XOMA (US) LLC | 3 |
| EyePoint Pharmaceuticals, Inc. | 2 |
| Johns Hopkins University | 2 |
| Lux Biosciences, Inc. | 2 |
| Nisha Acharya | 2 |
| Targeted Therapy Technologies, LLC | 2 |
| ACELYRIN Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uveitis, Intermediate | 56 |
| Uveitis | 40 |
| Uveitis, Posterior | 40 |
| Panuveitis | 25 |
| Uveitis, Anterior | 11 |
| Macular Edema | 7 |
| Behcet Syndrome | 4 |
| Inflammation | 3 |
| Choroidal Effusions | 2 |
| Epiretinal Membrane | 2 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.